• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDM2、MDMX、Pirh2 和 COP1:p53 的负调控因子相互作用。

Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.

机构信息

State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200433, People's Republic of China.

出版信息

Mol Biol Rep. 2011 Jan;38(1):229-36. doi: 10.1007/s11033-010-0099-x. Epub 2010 Mar 24.

DOI:10.1007/s11033-010-0099-x
PMID:20333547
Abstract

MDM2, Pirh2 and COP1 are important E3 ubiquitin ligases, which directly interact with p53 and target p53 for proteasome-mediated degradation. MDMX, the MDM2 homologous protein, inhibits p53-mediated transcription activity. The interplay between MDM2, MDMX, Pirh2 and COP1 has not been reported, except the interaction between MDM2 and MDMX. Here, we reported that there were interactions between these four proteins independently of p53. The protein levels of MDM2, MDMX, Pirh2 and COP1 changed when any two of them were co-transfected. Our data also showed that the integrity of MDM2 RING finger domain was crucial for its ability to elevate the protein levels of COP1 and Pirh2. Any two of these four proteins could inhibit p53-mediated transcriptional activity synergistically. Furthermore, COP1 inhibited MDM2 self-ubiquitination and interfered with MDMX ubiquitination by MDM2. Our results suggest that MDM2, MDMX, Pirh2 and COP1 might inhibit p53 activity synergistically in vivo.

摘要

MDM2、Pirh2 和 COP1 是重要的 E3 泛素连接酶,它们直接与 p53 相互作用,并将 p53 靶向蛋白酶体介导的降解。MDMX 是 MDM2 的同源蛋白,可抑制 p53 介导的转录活性。除了 MDM2 和 MDMX 之间的相互作用外,MDM2、MDMX、Pirh2 和 COP1 之间的相互作用尚未被报道。在这里,我们报道了这四种蛋白质之间存在相互作用,而与 p53 无关。当其中两种蛋白质共转染时,MDM2、MDMX、Pirh2 和 COP1 的蛋白水平发生变化。我们的数据还表明,MDM2 RING 指结构域的完整性对于其提高 COP1 和 Pirh2 蛋白水平的能力至关重要。这四种蛋白质中的任意两种都可以协同抑制 p53 介导的转录活性。此外,COP1 抑制 MDM2 自身泛素化,并干扰 MDM2 对 MDMX 的泛素化。我们的结果表明,MDM2、MDMX、Pirh2 和 COP1 可能在体内协同抑制 p53 活性。

相似文献

1
Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.MDM2、MDMX、Pirh2 和 COP1:p53 的负调控因子相互作用。
Mol Biol Rep. 2011 Jan;38(1):229-36. doi: 10.1007/s11033-010-0099-x. Epub 2010 Mar 24.
2
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.Mdm2和MdmX融合蛋白的过表达会改变p53介导的反式激活、泛素化及降解过程。
Biochemistry. 2003 Mar 4;42(8):2291-9. doi: 10.1021/bi0271291.
3
A site-directed mutagenesis study of the MdmX RING domain.MdmX RING 结构域的定点突变研究。
Biochem Biophys Res Commun. 2014 May 16;447(4):696-701. doi: 10.1016/j.bbrc.2014.04.065. Epub 2014 Apr 19.
4
Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.与MdmX的异源寡聚化可挽救Mdm2的RING指突变体的泛素/Nedd8连接酶活性。
J Biol Chem. 2007 Apr 13;282(15):10901-7. doi: 10.1074/jbc.M610879200. Epub 2007 Feb 14.
5
p53 regulation: teamwork between RING domains of Mdm2 and MdmX.p53 调控:Mdm2 和 MdmX 的 RING 结构域之间的团队合作。
Cell Cycle. 2011 Dec 15;10(24):4225-9. doi: 10.4161/cc.10.24.18662.
6
Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.两种 p53 E3 连接酶 Mdm2 和 Pirh2 的 RING 结构域的结构与功能比较。
J Biol Chem. 2011 Feb 11;286(6):4796-808. doi: 10.1074/jbc.M110.157669. Epub 2010 Nov 17.
7
MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination.X 蛋白对于 Mdm2 蛋白介导的 p53 多泛素化是必需的。
J Biol Chem. 2011 Jul 8;286(27):23725-34. doi: 10.1074/jbc.M110.213868. Epub 2011 May 13.
8
Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice.MDM2 RING 结构域失活可增强小鼠 p53 的转录活性。
J Biol Chem. 2017 Dec 29;292(52):21614-21622. doi: 10.1074/jbc.RA117.000122. Epub 2017 Nov 9.
9
The ubiquitin ligase COP1 is a critical negative regulator of p53.泛素连接酶COP1是p53的关键负调控因子。
Nature. 2004 May 6;429(6987):86-92. doi: 10.1038/nature02514. Epub 2004 Apr 21.
10
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.Mdmx通过改变Mdm2泛素连接酶的底物偏好性来增强p53的泛素化。
FEBS Lett. 2009 Sep 3;583(17):2710-4. doi: 10.1016/j.febslet.2009.07.021. Epub 2009 Jul 18.

引用本文的文献

1
The Impact of Genetic Mutations on the Efficacy of Immunotherapies in Lung Cancer.遗传突变对肺癌免疫疗法疗效的影响。
Int J Mol Sci. 2024 Nov 7;25(22):11954. doi: 10.3390/ijms252211954.
2
Association between p73 RS2273953 to RS1801173 polymorphism and risk of lung cancer: a meta-analysis of 2,897 cases and 3,317 controls.p73基因RS2273953至RS1801173多态性与肺癌风险的关联:对2897例病例和3317例对照的荟萃分析。
Int J Clin Exp Pathol. 2023 Dec 15;16(12):357-367. eCollection 2023.
3
The Role of P53 in Myocardial Ischemia-Reperfusion Injury.

本文引用的文献

1
p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2.p53 通过转录 MDM2 促进致癌蛋白 HBx 的蛋白酶体依赖性降解。
Mol Biol Rep. 2010 Jul;37(6):2935-40. doi: 10.1007/s11033-009-9855-1. Epub 2009 Oct 16.
2
Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls.血清p53蛋白和抗p53抗体与癌症风险增加相关:一项针对569例患者和879名健康对照者的病例对照研究。
Mol Biol Rep. 2010 Jan;37(1):339-43. doi: 10.1007/s11033-009-9744-7. Epub 2009 Aug 20.
3
Modes of p53 regulation.
P53在心肌缺血再灌注损伤中的作用。
Cardiovasc Drugs Ther. 2025 Feb;39(1):195-209. doi: 10.1007/s10557-023-07480-x. Epub 2023 Jun 30.
4
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.癌症中靶向p53信号通路:分子机制与临床研究
MedComm (2020). 2023 May 28;4(3):e288. doi: 10.1002/mco2.288. eCollection 2023 Jun.
5
Independent role of caspases and Bik in augmenting influenza A virus replication in airway epithelial cells and mice.半胱天冬酶和 Bik 在增强呼吸道上皮细胞和小鼠中甲型流感病毒复制中的独立作用。
Virol J. 2023 Apr 24;20(1):78. doi: 10.1186/s12985-023-02027-w.
6
Mechanism and Disease Association With a Ubiquitin Conjugating E2 Enzyme: UBE2L3.泛素连接酶 E2 酶 UBE2L3 的作用机制及与疾病的关联
Front Immunol. 2022 Feb 21;13:793610. doi: 10.3389/fimmu.2022.793610. eCollection 2022.
7
Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma.靶向RFWD2作为抑制多发性骨髓瘤细胞增殖和克服对蛋白酶体抑制剂耐药性的有效策略。
Front Cell Dev Biol. 2021 Apr 21;9:675939. doi: 10.3389/fcell.2021.675939. eCollection 2021.
8
Amniotic Fluid Cells, Stem Cells, and p53: Can We Stereotype p53 Functions?羊水细胞、干细胞和 p53:我们能否对 p53 功能定型?
Int J Mol Sci. 2019 May 7;20(9):2236. doi: 10.3390/ijms20092236.
9
Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis.阐明调节细胞凋亡的泛素蛋白酶体系统的串扰机制。
Front Cell Dev Biol. 2018 Feb 9;6:11. doi: 10.3389/fcell.2018.00011. eCollection 2018.
10
Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway.姜黄素 IIA 通过 MDM4-IAP3 信号通路抑制 H1299 细胞活力。
Mol Med Rep. 2018 Feb;17(2):2384-2392. doi: 10.3892/mmr.2017.8152. Epub 2017 Nov 24.
p53的调控模式。
Cell. 2009 May 15;137(4):609-22. doi: 10.1016/j.cell.2009.04.050.
4
Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?癌症治疗中靶向Mdm2和Mdmx:通过药物化学实现更好的生存?
Mol Cancer Res. 2009 Jan;7(1):1-11. doi: 10.1158/1541-7786.MCR-08-0423.
5
Regulation of MDMX expression by mitogenic signaling.有丝分裂原信号对MDMX表达的调控。
Mol Cell Biol. 2008 Mar;28(6):1999-2010. doi: 10.1128/MCB.01633-07. Epub 2008 Jan 2.
6
PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.PLAGL2控制Pirh2的稳定性,Pirh2是一种针对p53的E3泛素连接酶。
Biochem Biophys Res Commun. 2007 Dec 14;364(2):344-50. doi: 10.1016/j.bbrc.2007.10.003. Epub 2007 Oct 11.
7
ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.DNA损伤后,共济失调毛细血管扩张突变蛋白(ATM)促使E3泛素连接酶COP1发生自降解。
Science. 2006 Aug 25;313(5790):1122-6. doi: 10.1126/science.1127335.
8
Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.HAUSP介导的去泛素化作用的丧失导致DNA损伤诱导的Hdmx和Hdm2的不稳定。
Mol Cell. 2005 May 27;18(5):565-76. doi: 10.1016/j.molcel.2005.04.024.
9
Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer.新型泛素蛋白连接酶Pirh2在肺癌中的表达。
J Natl Cancer Inst. 2004 Nov 17;96(22):1718-21. doi: 10.1093/jnci/djh292.
10
COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas.COP1是p53的负调控因子,在乳腺和卵巢腺癌中过表达。
Cancer Res. 2004 Oct 15;64(20):7226-30. doi: 10.1158/0008-5472.CAN-04-2601.